Ongue, Nikki Lyn T.
HRN: 16-03-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2023
CEFUROXIME 1.5GM (VIAL)
02/05/2023
02/12/2023
IV
465mg
Q8hours
UTI; PCAP-B
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes